Literature DB >> 9166193

Elevated levels of serum nitrate, a stable end product of nitric oxide, in women with pre-eclampsia.

A K Smárason1, K G Allman, D Young, C W Redman.   

Abstract

OBJECTIVES: Nitric oxide released from vascular endothelial cells is a potent vasodilator and inhibits platelet adhesion. It has been suggested that decreased nitric oxide production from dysfunctional endothelial cells is implicated in the pathophysiology of pre-eclampsia. In this study evidence was sought for abnormal production of nitric oxide in pre-eclamptic women. PARTICIPANTS: Blood was collected from 20 women presenting with pre-eclampsia, from 20 matched healthy pregnant controls and from 12 nonpregnant women of childbearing age.
METHODS: Serum nitrate, the stable end metabolite of nitric oxide, was measured by vanadium III chloride reduction and chemiluminescence.
RESULTS: Sera from women with pre-eclampsia had significantly higher nitrate concentrations (mean 47.4 mumol/L [SD 13.6]) compared with healthy pregnant (mean 31.2 mumol/L [SD 9.14]) and nonpregnant (mean 32.1 mumol/L [SD 10.0]) controls.
CONCLUSIONS: These results do not support the hypothesis that decreased endothelial cell nitric oxide production may be important in the pathophysiology of pre-eclampsia. On the contrary, serum nitrate levels are increased which may reflect either increased production of nitric oxide from an unidentified source or decreased elimination through the kidneys.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9166193     DOI: 10.1111/j.1471-0528.1997.tb11528.x

Source DB:  PubMed          Journal:  Br J Obstet Gynaecol        ISSN: 0306-5456


  21 in total

1.  Nitric oxide, lipid peroxidation and total thiol levels in acute appendicitis.

Authors:  Fatma Meriç Yilmaz; Gülsen Yilmaz; Mehmet Fatih Erol; Seyfettin Köklü; Doğan Yücel
Journal:  J Clin Lab Anal       Date:  2010       Impact factor: 2.352

2.  Analysis of nitroso-proteomes in normotensive and severe preeclamptic human placentas.

Authors:  Hong-hai Zhang; Yu-ping Wang; Dong-bao Chen
Journal:  Biol Reprod       Date:  2011-01-12       Impact factor: 4.285

Review 3.  PPAR-γ -- a possible drug target for complicated pregnancies.

Authors:  Fergus P McCarthy; Aoife C Delany; Louise C Kenny; Sarah K Walsh
Journal:  Br J Pharmacol       Date:  2013-03       Impact factor: 8.739

4.  Measuring Nitrite and Nitrate, Metabolites in the Nitric Oxide Pathway, in Biological Materials using the Chemiluminescence Method.

Authors:  Barbora Piknova; Ji Won Park; Katelyn S Cassel; Cameron N Gilliard; Alan N Schechter
Journal:  J Vis Exp       Date:  2016-12-25       Impact factor: 1.355

5.  Effect of novel vitamin D receptor activator paricalcitol on renal ischaemia/reperfusion injury in rats.

Authors:  A Azak; B Huddam; N Haberal; G Koçak; L Ortabozkoyun; M Şenes; M F Akdoğan; N Denizli; M Duranay
Journal:  Ann R Coll Surg Engl       Date:  2013-10       Impact factor: 1.891

Review 6.  Preeclampsia beyond pregnancy: long-term consequences for mother and child.

Authors:  Hannah R Turbeville; Jennifer M Sasser
Journal:  Am J Physiol Renal Physiol       Date:  2020-04-06

7.  Sildenafil increases uterine blood flow in nonpregnant nulliparous women.

Authors:  Sarah A Hale; Cresta W Jones; George Osol; Adrienne Schonberg; Gary J Badger; Ira M Bernstein
Journal:  Reprod Sci       Date:  2010-04       Impact factor: 3.060

8.  The effects of caffeine on L-arginine metabolism in the brain of rats.

Authors:  Ebru Ofluoglu; Hatice Pasaoglu; Aydin Pasaoglu
Journal:  Neurochem Res       Date:  2008-07-10       Impact factor: 3.996

9.  Is Xanthine Oxidase, a Marker in Pre-eclampsia? A Case-Control Study.

Authors:  Vanishree Bambrana; C D Dayanand; Pushpa P Kotur
Journal:  J Clin Diagn Res       Date:  2015-10-01

10.  Evaluation of the Possible Mechanisms of Antihypertensive Activity of Loranthus micranthus: An African Mistletoe.

Authors:  Bamidele A Iwalokun; Sedoten A Hodonu; Stella Nwoke; Olabisi Ojo; Phillip U Agomo
Journal:  Biochem Res Int       Date:  2011-09-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.